REGULATORY

Chuikyo to Discuss Annual Price Revision Plan in Concert with CEFP: Official

December 22, 2016

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Future agenda items for the introduction of annual price revisions will be discussed by the health ministry’s Central Social Insurance Medical Council (Chuikyo) in coordination with the Council on Economic and Fiscal Policy (CEFP), Prime Minister Shinzo Abe’s key advisory…

To read the full story

PM Abe’s Panel to Keep Vigilant Eyes on Drug Prices, Reimbursement Fees
December 22, 2016
Four Ministers Map Out Basic Policy for Drug Pricing Revamp
December 21, 2016
Basic Policy for Drastic Reform of Drug Pricing System
December 20, 2016

REGULATORY

MHLW Pharma Director Says Uniform Drug Price Hike “Not Realistic,” Targeted Support Preferred
January 9, 2026
MHLW Issues Guidance on Revised PMD Act Ahead of May Enforcement
January 6, 2026
MHLW Sets Up Drug Discovery Support Office Ahead of New Fund Launch
January 6, 2026
Ex-JPMA President Ueno Takes on New AMED Advisor Role
January 6, 2026
Cabinet OKs FY2026 Tax Reform Package, Creates Strategic Tech R&D Credit
January 5, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Gist of FY2026 Drug Pricing Reform Outline

The Central Social Insurance Medical Council, a key Japanese reimbursement policy panel better known as Chuikyo, approved an outline of…

COMMENTARY

Wave of “World Firsts” Looms as 47 New Drug Candidates Line Up for 2026

By Shinya Sato

As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…